Search Results for: Galmed

Investment in Israeli startups 28/2/21

Posted on February 28, 2021

CYE raised $120 million; Gamida Cell raised $75 million; Personetics raised $75 million; Pliops raised $65 million; PerimeterX raised $57 million; Lusha raised $40 million; Redefine Meat raised $29 million; Atera raised $25 million; Nanit raised $25 million; EquityBee raised … Continue reading →

Posted in Economy & Business | Leave a comment

Good trial results for NASH treatment

Posted on April 14, 2019

I reported previously (Oct 2014) that the Aramchol treatment from Israel’s Galmed for Non-Alcoholic Steatohepatitis (NASH) had been fast-tracked by the US FDA. Latest trials show that twice-daily dosages of Aramchol significantly increased blood plasma levels. http://galmedpharma.investorroom.com/2019-03-12-Galmed-Reports-Positive-Results-From-Pharmacokinetic-Split-Dose-Study-of-Aramchol

Posted in Israel's Medical Achievements | Leave a comment

Hepatitis treatment fast-tracked

Posted on October 5, 2014

The US FDA has awarded Fast Track Designation to Israeli biotech Galmed for its Aramchol treatment of Non-Alcoholic Steato-Hepatitis, or NASH.  Galmed is to perform Phase IIb trials of Aramchol this year with 240 NASH patients who also suffer from … Continue reading →

Posted in Israel's Medical Achievements | Leave a comment